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Pericytes are specialized mural cells located at the abluminal surface of capillary
blood vessels, embedded within the basement membrane. In the vascular network
these multifunctional cells fulfil diverse functions, which are indispensable for proper
homoeostasis. They serve as microvascular stabilizers, are potential regulators of
microvascular blood flow and have a central role in angiogenesis, as they for example
regulate endothelial cell proliferation. Furthermore, pericytes, as part of the neurovascular
unit, are a major component of the blood-retina/brain barrier. CNS pericytes are a
heterogenic cell population derived from mesodermal and neuro-ectodermal germ
layers acting as modulators of stromal and niche environmental properties. In addition,
they display multipotent differentiation potential making them an intriguing target for
regenerative therapies. Pericyte-deficiencies can be cause or consequence of many
kinds of diseases. In diabetes, for instance, pericyte-loss is a severe pathological process
in diabetic retinopathy (DR) with detrimental consequences for eye sight in millions of
patients. In this review, we provide an overview of our current understanding of CNS
pericyte origin and function, with a special focus on the retina in the healthy and diseased.
Finally, we highlight the role of pericytes in de- and regenerative processes.
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INTRODUCTION
Pericytes are specialized cells located at the abluminal surface of capillary blood vessels with
key functions in vascular homoeostasis (Díaz-Flores et al., 2009). They were first described
in the 1870’s by Eberth (1871) and Rouget (1879) and at that time named after the
investigator ‘‘Rouget cells’’. Due to their location in close proximity to endothelial cells, and
their perivascular association to the microvasculature, Zimmermann (1923) later renamed them
to ‘‘pericytes’’. However, the definition and also proper identification of pericytes remains
challenging. Depending on the vascular bed and their differentiation state, pericytes exhibit
varying morphologies and express different marker profiles. In the last decades functional
roles of pericytes in blood vessel stabilization (von Tell et al., 2006), in blood flow regulation
Abbreviations: CNS, central nervous system; vSMC, vascular smooth muscle cells; GFP, green fluorescent protein;
BM, bone marrow; BRB, blood retina barrier; BBB, blood brain barrier.
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(Hamilton et al., 2010), and in the formation of the blood-
brain/retina barrier (BBB/BRB; Zlokovic, 2008; Bell et al., 2010;
Winkler et al., 2011; Pfister et al., 2013) have been demonstrated.
Further, pericytes possess a multipotent differentiation potential,
which allows for generation of various different cell types (Crisan
et al., 2009; Díaz-Flores et al., 2009). Due to this multipotency,
these cells are a potential target for tissue repair and therapeutic
approaches in regenerative medicine (Ozen et al., 2012).
This review covers pericytes within the central nervous
system (CNS), focusing on retinal pericytes and their vascular
functions as well as their contribution to retinal pathology
progression. Because of its identical embryological origin, the
mammalian retina is considered a part of the CNS. The
nutrition of the retina is provided by two different vascular
beds: the outer retina (photoreceptors) is passively supplied by
the choroidal vasculature, whereas the inner retina is supplied
by the retinal vasculature. The latter is comparable to CNS
vasculature, constituting a tightly regulated cellular barrier.
Retinal pericytes are essential constituents of the BRB and
fulfill important functions to maintain vessel homeostasis. To
provide a more comprehensive vision, this review will also
include findings of other, non-retinal CNS pericytes. Finally,
next to describing the vascular function of CNS pericytes the
emerging hypothesis arguing in favor of a regenerative function
and hence a therapeutic use of pericytes in tissue repair will be
discussed.
ORIGIN OF PERICYTES
Pericytes are generated during embryonic and postnatal
life (Armulik et al., 2011; Winkler et al., 2011). During
developmental stages, CNS pericytes originate from
neuroectodermal neural crest cells as demonstrated by quail-
chick transplantation experiments of forebrain pericytes
(Etchevers et al., 2001). These findings were supported by
the possibility of neuroectodermal cells to differentiate into
pericytes and vascular smooth muscle cells (vSMCs) of
embryonic cerebral vessels (Korn et al., 2002). The neural
crest origin of retinal pericytes was demonstrated using a
Wnt-1 Cre-recombinase fate mapping mouse model, which
specifically labels neural crest and neural crest–derived
cells (Danielian et al., 1998; Gage et al., 2005). Within the
retina, choroid and optic nerve, a neural crest origin was
further demonstrated using a Sox10-Cre neural crest fate
mapping mouse model (Trost et al., 2013). Along these
lines, Simon et al. (2012) reported GFP-positive pericytes
in the cortical gray matter using an inducible Sox10-Cre
eGFP mouse model. Finally, neural crest origin of pericytes
has also been described in thymic vessels of Wnt-1-Cre
(Müller et al., 2008) and Sox10-Cre (Foster et al., 2008) mouse
models.
In addition to the neural crest origin, pericytes potentially also
derive from mesodermal cells (Etchevers et al., 2001). Using a
XlacZ4 reporter under the control of an adipose tissue specific
promoter (aP2), Tidhar et al. (2001) demonstrated reporter gene
expression in vSMCs and pericytes throughout the vascular
bed, including retinal microvessels. Also, bone marrow (BM)
cells can be recruited during tumor- and cytokine-induced
neoangiogenesis, giving rise to cells morphologically resembling
pericytes and expressing the pericyte marker chondroitin sulfate
proteoglycan 4/neural glial antigen 2 (NG2; Rajantie et al.,
2004; Ziegelhoeffer et al., 2004; Song et al., 2005; Lamagna
and Bergers, 2006). Finally, in corneal neovascularization almost
half of the neovascular pericytes are BM-derived (Ozerdem
et al., 2005). Also, fate mapping of GFP labeled BM using
the stem cell antigen 1 promoter (sca-1), illustrated a BM
origin of pericytes and a contribution of these cells to vascular
remodeling during postnatal retinal angiogenesis as well as
pathological angiogenesis in the retina (Pfister et al., 2013).
Taken together, these data strongly suggest a mesodermal
origin of pericytes resembling a pericyte reservoir for postnatal
pathological neoangiogenesis.
IDENTITY OF PERICYTES
Under physiological conditions pericytes are located at the
abluminal surface of microvessels, embedded in a common
basement membrane with endothelial cells (Figure 1). The
cytoplasmic processes of pericytes can span several endothelial
cells and can have different morphologies (Dore-Duffy and
Cleary, 2011), depending on the vascular bed and their
differentiation/developmental state. The pericyte density and
microvascular coverage varies according to the vascular bed,
revealing the highest density in the CNS (Tilton et al., 1985; Frank
et al., 1990).
Although the identification of pericytes by ultrastructural
analysis may represent the ‘‘gold standard’’, this method is not
applicable in every experimental setting. Therefore a variety
of potential pericyte-specific histological markers have been
proposed (reviewed in Armulik et al., 2011), including platelet-
derived growth factor receptor β (PDGFRb; Lindahl et al.,
1997; Winkler et al., 2010), NG2 (Ozerdem et al., 2001; Trost
et al., 2013), CD13 (Kunz et al., 1994), desmin (Nehls et al.,
1992), vimentin (Bandopadhyay et al., 2001). In addition, the
potassium channel complex Kir 6.1 has been used as a marker
particular for CNS pericytes (Bondjers et al., 2006; Table 1).
On the other hand, pericytes are negative for endothelial cell
markers such as CD31 and von Willebrand factor and markers
of other perivascular cell types, such as glial cells (GFAP, Olig2),
microglial cells (Iba1) and neuronal cells. For the identification
of retinal pericytes a combination of NG2 and PDGFRb can be
recommended based on recently published data (Trost et al.,
2013). However, it is important to note that the expression of
antigens may differ for in vitro and in vivo conditions. For
example, alpha smooth muscle actin (aSMA) has widely been
used to identify pericytes and vSMCs in vitro and in vivo,
however capillary pericytes do not express aSMA in vivo (Nehls
and Drenckhahn, 1991; Trost et al., 2013; Hill et al., 2015).
Therefore, aSMA labels vSMCs located on larger vessels, but
not capillary pericytes. As several other markers such as NG2,
PDGFRb or desmin are expressed by pericytes and vSMCS the
identification and discrimination of these two cell types cannot
be based solely on marker expression, but vascular localization
must also be considered. As demonstrated in Figure 2, vSMCs
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FIGURE 1 | Localization of pericytes within the retinal vasculature. (A) Retinal vasculature, showing a single neural glial antigen 2 (NG2)-positive (green)
vSMCs layer on arterioles (art) and single NG2-positive pericytes on capillaries (c, arrowheads; in accordance with results in Trost et al., 2015). (B) Illustration of the
localization of pericytes on capillaries. (B′) Pericytes are located abluminal of endothelial cells, (B′′) wrapping around the capillary, embedded within the same
basement membrane as demonstrated in a capillary cross-section.
TABLE 1 | Summary of pericyte markers.
Marker Reference
PDGFRb Platelet-derived growth factor receptor β Lindahl et al. (1997) and Winkler et al. (2010)
NG2 Chondroitin sulfate proteoglycan 4/neural glial antigen 2 Ozerdem et al. (2001) and Trost et al. (2013)
CD13 Alanyl membrane aminopeptidase Kunz et al. (1994)
Vimentin Intermediate filament protein Bandopadhyay et al. (2001)
Desmin Desmin, structural protein Nehls et al. (1992)
Kir6.1 Potassium inwardly rectifiying channel, subfamily J, member 8 Bondjers et al. (2006)
on arterioles as well as pericytes on capillaries are labeled by
NG2, however aSMA identifies only vSMCs on arterioles and
is absent in retinal pericytes (Figure 2). This marker expression
profile indicates a morphological and biochemical continuum
from vSMC to pericytes, which is further supported by the
common expression of the neural crest specific marker Sox10
(Trost et al., 2013). However, under pathological conditions
pericytes may alter their expression. Therefore, the use of genetic
models permanently labeling pericytes and their progenies
(e.g., NG2-dsRed (Schallek et al., 2013) or NG2-CreERT2-eGFP
mouse model (Hill et al., 2015) is essential and will enable to
study the fate of pericytes also under pathological conditions).
In summary, the specific identification of pericytes currently
requires a combination of at least two markers as well as the
consideration of the morphology and vascular localization and
some circumstances will require appropriate transgenic animal
models.
PERICYTE FUNCTIONS
Over the last decades different functions have been assigned to
pericytes: they fulfill important functions during (a) angiogenesis
and vessel stabilization; (b) participate in blood flow regulation
and neurovascular coupling; and (c) are an essential constituent
of the BBB/BRB. As mentioned above, next to their vascular
functions they possess a multipotent differentiation potential
(Figure 3).
Angiogenesis and Pericyte-Endothelial
Cell Interaction—The PDGF-B/PDGFRb
Signaling Pathway
Pericytes play a major role in angiogenesis, participating in vessel
formation, remodeling and stabilization (Gerhardt and Betsholtz,
2003). A number of signaling pathways and factors have been
reported to be important for the intercellular communication
between endothelial cells and pericytes, including transforming
growth factor β (TGF β), angiopoietins, platelet-derived
growth factor B (PDGF-B), spingosine-1-phosphate and Notch
(reviewed in Armulik et al., 2005, 2011; Winkler et al.,
2011).
Here, we will focus on PDGF-B/PDGFRb signaling, since
this pathway is involved in pericyte proliferation, migration,
survival and attachment. The importance of this signaling
pathway was highlighted using genetically modified depletion
and knockout models (reviewed in Betsholtz, 2004). During
angiogenesis, sprouting endothelial cells secrete PDGF-B, which
binds with high affinity to the pericyte-specific receptor
PDGFRb, leading to the recruitment and attachment of
pericytes. In general, impaired PDGF-B/PDGFRb signaling
results in a failure of pericyte recruitment and in reduced
microvascular pericyte coverage ultimately leading to endothelial
hyperplasia, abnormal vascular morphogenesis and formation
of microaneurysms (e.g., Lindahl et al., 1997; Hellström
et al., 2001). Further, genetic deletion of either pdgfrb
(Soriano, 1994) or pdgfb (Levéen et al., 1994) results in perinatal
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FIGURE 2 | Identification and discrimination of pericytes from vascular smooth muscle cells (vSMCs) in the retina visualizing NG2 and alpha smooth
muscle actin (aSMA) protein expression. (A) NG2 immunopositivity can be detected in both, retinal pericytes (representative arrow) and aSMA positive arteriolar
SMCs (representative arrowhead). (B) Retinal capillary pericytes lack the aSMA signal (arrows) and (C) can be therefore discriminated from vSMCs as illustrated in
the merged picture (in accordance with results in Trost et al., 2013).
death due to vascular dysfunction. The mutation of particular
downstream signal transduction molecule binding sites of
PDGFRb resulted in a reduction of pericyte coverage in the
heart and kidney vasculature, which was further decreased
by crossing these mutants with PDGFRb null allele mice
(Soriano, 1994). Investigating pericyte coverage in the retina
in mice with multiple mutations, a reduced number of
pericytes was detected and resulted in severe hemorrhage
(Tallquist et al., 2003). The importance of PDGF-B is
further underscored by studies demonstrating that ablation
of endothelial derived PDGF-B resulted in reduced retinal
pericyte coverage, leading to variable capillary and venous
diameter, regressing capillary branches and the presence
of microaneurysms. Furthermore, all mice showing <52%
of normal pericyte density developed signs of proliferative
retinopathy (Enge et al., 2002).
Another approach to investigate PDGF-B/PDGFRb signaling
is the deletion of the retention motif in PDGF-B. The localization
of the endothelial secreted PDGF-B in the vicinity of the
developing vessel is guaranteed by binding of the PDGF-B
retention motif to heparin sulfate proteoglycans (HSPG),
resulting in subsequent binding of PDGFRb expressing pericytes
to the endothelial tip cells (Lindblom et al., 2003; Armulik
et al., 2005). Deleting this motif leads to impaired recruitment
of pericytes, resulting in a severely disorganized retinal
vasculature with partially detached pericytes and processes
extending away from the vessel (Lindblom et al., 2003;
Genové et al., 2014). As the truncated PDGF-B protein
reveals full biological activity (Ostman et al., 1989), the
endothelial localization of PDGF-B by the retention motif is
suggested to be responsible for proper pericyte embedment
in the microvessel wall. Besides the retention of PDGF-B at
FIGURE 3 | Schematic overview of (the main) pericyte functions.
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the developing vessel, the tissue concentration of PDGF-B
is important for determining retinal pericyte density, as
revealed by a reduction in pericyte coverage in mice with a
monoallelic deficiency of PDGF-B (PDBF-B+/−; Hammes et al.,
2002).
The impact of transgenic overexpression of PDGF ligands
has also been investigated. Specific overexpression of PDGF-B
in photoreceptor cells resulted in increased proliferation of
pericytes, but also astrocytes and endothelial cells. These cells
formed disorganized sheets and cords migrating into the inner
retina, causing retinal tractions which ultimately resulted in
a phenotype resembling retinal detachment in proliferative
retinopathies. Furthermore, the formation of the deep capillary
bed was inhibited in PDGF-B overexpressing mice (Seo et al.,
2000; Mori et al., 2002; Vinores et al., 2003). The pathogenic
effect of ectopic PDGF-B expression on retinal architecture
and development was also demonstrated by overexpressing
PDGF-B under the control of the myelin basic protein
promoter (myelinating tracts), showing capillary and retinal
disorganization (Forsberg-Nilsson et al., 2003). In line with this,
expression of PDGF-B under the control of the nestin enhancer
element (active in progenitor cells during development) resulted
in severe retinal developmental defects, such as retinal folding,
disorganized retinal lamination, delayed and abnormal vascular
development, and progressive retinal degeneration (Edqvist et al.,
2012).
It can be concluded that the balanced and well controlled
secretion of endothelial PDGF-B, proper binding in close vicinity
to the sprouting vessel and the function of the pericyte’s PDGFRb
are essential for the proper development and maintenance of
the CNS vasculature in general, and the retinal vasculature in
particular.
Blood Flow Regulation and Neurovascular
Coupling
As pericytes express contractile proteins (Bandopadhyay et al.,
2001) and are located on capillaries abluminal of endothelial cells,
where vSMCs are absent, they are proposed to participate in
microvascular blood flow regulation. Although the contractility
and responsiveness of pericytes to vasoactive peptides has
been demonstrated in vitro (Markhotina et al., 2007), concisive
in vivo data remain limited. Evidence for pericyte contractility
in response to vasoactive molecules/neurotransmitters was
demonstrated using isolated retinal vessels (Kawamura et al.,
2003; Wu et al., 2003) and by in situ studies using isolated
rat retina (Schönfelder et al., 1998; Peppiatt et al., 2006) and
cerebellar slices (Peppiatt et al., 2006). In line with these
findings, Fernández-Klett et al. (2010) demonstrated the ability
of pericytes to modulate local cerebral capillary blood flow in
brain slice preparations in situ and cortex in vivo. In contrast,
Hill et al. (2015) excluded a contribution of CNS pericytes to
regulate cerebral blood flow on the capillary level. Focusing on
aSMA-negative pericytes located on capillaries with a diameter
of >10 µm, the authors detected a highly variable spontaneous
vasomotion and calcium fluctuations, not correlating with
changes in vessel diameter.
In vivo contractility of CNS pericytes and their influence
on neurovascular coupling has been investigated in brain and
to a lesser extent in retinal microvessels. The response of
regional blood flow to neuronal activity (functional hyperemia)
involves the interaction between neurons, glia and vascular cells
(neurovascular coupling). Although Fernández-Klett et al. (2010)
demonstrated active pericyte contraction after vasoconstrictor
addition, they were unable to provide evidence that pericytes
participate in neurovascular coupling after neuronal activity-
induced hyperemia. In contrast, Hall et al. (2014) showed
that cerebral pericytes actively dilate the capillaries after
electrical whisker pad stimulation, where capillary dilation
precedes arteriolar dilation. Although in both studies a similar
experimental set-up was applied to monitor dilations of cerebral
capillaries in response to neuronal activation, the mode of
electrical stimulation to increase capillary blood flow was
different and may account for the conflicting findings on the
impact/ability of pericytes to increase cerebral blood flow.
Studying the impact of retinal pericytes on capillary blood
flow regulation, the dilation of intermediate layer capillaries
upon flicker stimuli was proposed to be mediated by active
relaxation of pericytes, however without presenting direct
evidence that pericytes actively dilated. Nevertheless, the authors
concluded that functional hyperemia is driven primarily by active
dilation of retinal arterioles, covered by vSMCs (Kornfield and
Newman, 2014).
Although single studies propose a lack of pericyte contractility
(Hill et al., 2015), currently the majority of studies suggests that
CNS pericyte contractility is important to regulate local blood
flow under pathological conditions, such as traumatic brain
injury (Dore-Duffy et al., 2011) or ischemia (Peppiatt et al.,
2006; Yemisci et al., 2009; Hall et al., 2014). Nevertheless, the
active regulation of the capillary blood flow by pericytes remains
a controversial issue, most likely due to the poor definition
and identification of pericytes. Although several studies suggest
pericytes to possess an important role in neurovascular coupling,
more experimental in vivo evidence and a standardized definition
of pericytes is necessary to compare and combine findings on
the role of pericytes in blood flow regulation. Certainly, the use
of genetically modified mice, labeling pericytes as well as vSMC
in combination with pericytic markers will provide a more in
depth and standardized tool to study the contribution of pericytes
in blood flow regulation. Investigating pericytes in the retina
for example, Schallek et al. (2013) imaged retinal pericytes non-
invasively in the living eye using the NG2-dsRed mouse model.
This model, also used to investigate cerebral blood flow (Hall
et al., 2014), represents a great tool to study the impact of retinal
pericytes on the regulation of capillary diameter.
Blood-Brain-Barrier/Blood-Retina-Barrier
and Associated Diseases
In the last 20 years, pericytes have been proven to be an essential
constituent of the BBB and BRB. The BBB/BRB is a highly
regulated barrier, controling paracellular flow between cells
and transendothelial fluid transport, ensuring optimal chemical
composition of the neuronal microenvironment and at the same
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time protecting from potential harmful substances. Although
the main role in BBB/BRB tightness is mediated by tight and
adherens junctions between endothelial cells, several studies
have demonstrated that pericytes form and maintain together
with endothelial, neuronal and glial cells the BBB/BRB and
guarantee barrier function and tissue homeostasis. The BRB is
composed of the inner BRB (retinal capillary endothelial cells)
and the outer BRB (retinal pigment epithelial cells). Although
the BBB is structurally similar to the inner BRB and both
express several common transporters/receptors (Mori et al.,
2003; Hosoya et al., 2009), some reports describe heterogeneous
transport properties of the brain and retina neurovascular
unit (André et al., 2012). The impact of pericyte loss to BBB
and BRB breakdown and subsequent increased permeability
has been reported in a multitude of studies: using PDGFRb
signaling deficient mice (Pdgfrb+/+, Pdgfrb+/−, Pdgfrb-F7), Bell
et al. (2010) demonstrated that reduced pericyte coverage in
the brain results in BBB breakdown and an accumulation
of plasma derived proteins, ultimately resulting in secondary
neuronal degenerative alterations (e.g., impairments in learning
and memory). Increased BBB permeability through pericyte
deficiency was further demonstrated in studies using pericyte
deficient mouse mutants (Pdgfbret/ret and R26P+/−, R26P+/0)
indicating a regulatory role of pericytes on the gene expression
profile of endothelial cells and astrocytes (Armulik et al.,
2010). The crucial role of pericytes in BBB formation was
also confirmed during embryogenesis. Using different PDGFRb
mouse mutants with reduced pericyte coverage (Pdgfrb−/−,
PdgfrbF7/F7, PdgfbF7/−), Daneman et al. (2010) demonstrated a
correlation of BBB permeability with pericyte loss, concluding
that the pericyte amount determines the relative permeability
of CNS vessels during development. The impact of pericytes
on BBB mechanisms and subsequent neuronal damage has
been investigated extensively using the aforementioned mouse
models, however only few studies also investigated the impact
of reduced pericyte coverage on BRB permeability and neuronal
damage in the retina. Using endothelial specific PDGF-B
transgenic mice (Pdgf-bret/ret , Pdgf-blox/−, Pdgf-b−/−), a loss of
neuronal layers and folding of the photoreceptor layer in the
retina was associated with reduced pericyte coverage, resembling
signs of diabetic retinopathy (DR; Enge et al., 2002; Lindblom
et al., 2003). Further, investigating tight junction formation in
the developing retinal vasculature within the first three postnatal
weeks, the contribution of pericytes to tight junction and
BRB formation was demonstrated by the increased expression
of the tight junction protein ZO-1 during maturation and
enhanced pericyte coverage (Kim et al., 2009). However, a
limitation of this study is the identification of pericytes using
aSMA. As mentioned above, the development of tight junctions
interconnecting endothelial cells is crucial for an intact BBB and
the contribution of pericytes to tight junction formation at the
BRB has been confirmed by electron microscopy in vivo as well
as in endothelial-pericyte co-culture models (Daneman et al.,
2010).
Taken together, as a disrupted BBB/BRB is associated with
a variety of neuropathological processes, in vitro (Wisniewska-
Kruk et al., 2012) as well as in vivomodels are important to study
the underlying mechanisms.
PERICYTES IN RETINAL DISEASE AND
NEUROPATHOLOGIES
Altered pericyte function and coverage have been described in
diverse CNS diseases (reviewed in Lange et al., 2013). Diseases
with a clear pericyte participation include DR (Beltramo and
Porta, 2013), neonatal intraventricular hemorrhage (Braun
et al., 2007), Alzheimer’s disease (AD; Winkler et al., 2014)
or amyotrophic lateral sclerosis (ALS; Winkler et al., 2013) as
well as diverse rare diseases like Cerebral Autosomal Dominant
Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
(CADASIL; Table 2). One of the best studied pathological
conditions associated with reduced pericyte coverage in
the retina is DR. DR is a major complication of diabetes
mellitus, characterized by increased vascular permeability (BRB
breakdown), progressive vascular occlusion, microaneurysms
and neuronal changes ultimately resulting in vision threatening
diabetic macular edema and proliferative DR (Hammes et al.,
2002, 2011). Although the pericyte loss is a well established fact of
DR pathology, the underlying mechanisms for the development
and progression of DR remain unclear (Frank, 2004; Qian
and Ripps, 2011; Klaassen et al., 2013). Pericyte loss through
apoptosis and destructive pathways under hyperglycemic
conditions has been suggested (Behl et al., 2008, 2009). Altered
glutamate excitation, reduced trophic factor signaling, oxidative
stress, and neuroinflammation have also been associated with
increased pericyte apoptosis (reviewed in Barber et al., 2011).
TABLE 2 | Excerpt of diseases with associated pericyte dysfunction.
Disorders Findings Reference
Diabetic retinopathy Reduced retinal pericyte coverage Hammes et al. (2002, 2011), Beltramo and Porta (2013),
and Klaassen et al. (2013)
Neonatal intraventricular hemorrhage Decreased brain pericyte coverage Braun et al. (2007)
Alzheimers disease Degeneration of brain pericytes Farkas et al. (2000), Sengillo et al. (2013), Sagare et al. (2013),
Winkler et al. (2014), and Halliday et al. (2015)
Amyotrophic lateral sclerosis Reduced pericyte coverage Winkler et al. (2013)
CADASIL Robinson et al. (2001), Haritoglou et al. (2004), and Roine et al. (2006)
Adams oliver syndrome Reduced pericyte coverage Patel et al. (2004)
Multiple sclerosis Reduced brain pericyte amount Kunz et al. (1995)
Stroke Loss of capillary pericytes Fernández-Klett et al. (2013)
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 February 2016 | Volume 10 | Article 20
Trost et al. The Biology of CNS Pericytes
Next to these alterations, growth factor-mediated pericyte
depletion via angiopoietin-2/Tie-2 has been suggested (Hammes
et al., 2004; Pfister et al., 2008; Park et al., 2014).
Different genetically modified mouse models as well as
pharmacologically induced diabetic rodent models (Enge
et al., 2002; Huang et al., 2011; Lai and Lo, 2013; Qiu et al.,
2015) have been used to study the molecular mechanisms
of pericyte loss and vascular leakage in DR, but despite
these available models, BRB breakdown remains poorly
understood. Recently, Jadeja et al. (2013) characterized the
causative mutation in the ‘‘redeye’’ mouse, identifying a
mutation in the PDGFRb gene resulting in a reduction of
normal/wt PDGFRb transcript. They verified this mouse being
a useful model to study non-proliferative DR, demonstrating
CNS-restricted, reduced pericyte coverage and BRB leakage
followed by retinal neurodegeneration (i.e., reduced number of
RGCs; Jadeja et al., 2013). To study the underlying molecular
mechanisms at later stages of DR, the recently developed
Akimba (Ins2AkitaVEGF+/−) mouse, developing retinal
leakage, neovascularization with hyperglycemia and signs
of advanced clinical DR (diabetic macular edema, proliferative
DR) might represent a suitable model (Wisniewska-Kruk et al.,
2014).
The impact of pericytes as well as reduced pericyte coverage
on microvessels is also discussed to contribute to glaucoma.
While single studies report increased leakage of the BRB in the
optic nerve head (ONH) in glaucomatous patients (Arend et al.,
2005; Grieshaber and Flammer, 2007), the tightness of the BRB
in this disease remains unclear. The density or degeneration
of capillaries has been analyzed in several studies (May and
Mittag, 2006; Mi et al., 2012; Almasieh et al., 2013), and vascular
dysregulation has been suggested to be an important factor
in the pathogenesis of glaucoma (Venkataraman et al., 2010).
However, investigating pericyte coverage in an acute short-term
glaucoma model revealed no alteration in pericyte coverage
(Trost et al., 2015) and further studies are needed to understand
the contribution of pericytes in the glaucomatous diseases.
Similarly to the retina, pericyte loss and dysfunction has also
been reported to be associated with neurodegenerative disorders
in other CNS regions. The degeneration of brain pericytes by
specific amyloid-beta has been demonstrated by several studies
in vitro (Verbeek et al., 2000; Rensink et al., 2002). In cerebral
microvessels of patients suffering from AD, a degeneration of
pericytes has been observed in vivo (Farkas et al., 2000) and this
phenomenon was correlated with the severity of BBB breakdown
(Sengillo et al., 2013). This finding was also confirmed in AD
mouse models (Sagare et al., 2013; Halliday et al., 2015) further
suggesting a contribution of pericytes to the pathogenesis of AD.
Therefore, pericytes may represent a potential therapeutic target
for AD (reviewed in Winkler et al., 2014).
Further, vSMC and pericyte degeneration has been described
for the CADASIL syndrome caused byNOTCH 3 genemutations
(Dziewulska and Lewandowska, 2012; Gu et al., 2012; Craggs
et al., 2015). It has been speculated that ischemic events and
a consequently increased BBB permeability may account for
the observed severe injury to the cerebral white matter in
these patients. In addition, pericyte and vSMC degeneration
has been confirmed in retinal vessels of CADASIL patients
(Haritoglou et al., 2004), which is in accordance with observed
alterations of the retinal vasculature (Robinson et al., 2001; Roine
et al., 2006). In line with the above described findings, recently
the aggregation of mutated Notch3 receptors on pericytes
has been associated with the reduction of pericyte number
and coverage of cerebral microvessels, resulting in the loss of
BBB integrity and subsequent leakage of plasma proteins in a
CADASIL mouse model (TgNotch3R169C; Ghosh et al., 2015).
Another disease characterized by reduced pericyte coverage is
the Adams-Oliver-Syndrome (AOS), associated with severe scalp
and limb defects as well as impaired cardiovascular function
(Patel et al., 2004). Furthermore, in an experimental mouse
model for multiple sclerosis (MS), a reduction of pericytes
has been detected and correlated to the functional state of
the BBB (Kunz et al., 1995). As BBB dysregulation and
transendothelial migration of activated leukocytes are among
the earliest cerebrovascular abnormalities in MS (Ortiz et al.,
2014), the contribution of pericytes to MS pathology is very
likely. Finally, inducing cerebral ischemia in wild-type and
pericyte specific reporter mice (rgs5GFP), as well as investigating
histological samples of human stroke brains, Fernández-Klett
et al. (2013) reported a progressive loss of capillary pericytes at
the lesioned region.
Considering the fundamental role of pericytes in the
formation and maintenance of the BRB/BBB and the impact of
pericyte dysfunction pericytes represent a potential target for
therapeutic therapies.
PERICYTES AND TISSUE REGENERATION
Pericytes represent a very heterogeneous cell type displaying
different embryonic origins ranging from mesodermal to
neuroectodermal germ layers. Their capacity to differentiate
into mesenchymal cell types (e.g., adipocytes, chondrocytes,
osteoblasts, fibroblasts, vSMCs) has been proven in a multitude
of studies (reviewed in Díaz-Flores et al., 2009), including CNS
and especially retinal pericytes (Canfield et al., 1996; Doherty
et al., 1998; Farrington-Rock et al., 2004). Furthermore, pericytes
have the ability to differentiate also into non-mesenchymal cell
types, such as neural cells. For example, a recent study has
shown the differentiation of a skeletal muscle pericyte subtype
into Tuj1-expressing neurons (Birbrair et al., 2013). Moreover,
the ability of CNS pericytes to differentiate into neurons and
glial cells has been demonstrated (Dore-Duffy et al., 2006; Paul
et al., 2012) and CNS pericytes can be reprogrammed into
neuronal cells by ectopic expression of the pro-neurogenic fate
determinants Sox2 and Mash1 (Karow et al., 2012). A recent
study demonstrated that CNS pericytes, isolated from ischemic
brain regions, are able to differentiate into neural and vascular
lineage cells, suggesting their contribution to neurogenesis and
vasculogenesis at sites of brain injury (Nakagomi et al., 2015).
Besides the neural differentiation potential of CNS pericytes,
evidence for their ability to differentiate into stromal cells has
also been provided in spinal cord injury (SCI) models in vivo.
A specific pericyte subtype was demonstrated to give rise to
cells forming fibrotic scar tissue after SCI and was further
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found to be crucial for wound closure as shown by specific
depletion of this type A pericyte population (Göritz et al., 2011).
Consistent with these findings, a recent study proposed an
increase of PDGFRb+ pericytes in the injured spinal cord region,
intermingled with GFAP+ astrocytes (Matsushita et al., 2015).
Using a Nestin-GFP/NG2-dsRed fate mapping model, the type I
pericytes (Nestin−/NG2+) have been shown to participate in
scar formation after SCI (Birbrair et al., 2014), however as these
cells lack PDGFRb expression in the fibrous scar they probably
represent an additional pericyte subtype. Taken together, the
proliferation of CNS derived PDGFRb+ stromal cells, identified
as pericytes, has been described in SCI (Göritz et al., 2011;
Matsushita et al., 2015) and cerebral ischemia (Fernández-Klett
et al., 2013), indicating a crucial role of CNS pericytes in
pathological fibrotic processes, being a potential target for future
therapeutic strategies. Further the potential of CNS pericytes to
differentiate into mesodermal as well as neuroectodermal cell
types highlights their potential role in regenerative processes.
Due to their similarity to mesenchymal stem cells (MSCs),
in terms of their expression profile and their differentiation
potential as well as of their stromal capability, CNS pericytes
have been considered to be the ‘‘CNS-resident MSCs’’ (Lange
et al., 2013). Indeed, similarly to MSCs, CNS pericytes- release a
plethora of bioactive molecules able to regulate proliferation and
migration of CNS progenitor cells (Choe et al., 2014; Maki et al.,
2015). This last property provides pericytes with the ability to
regulate CNS endogenous progenitor/stem cell function during
development and regeneration. Therefore, on the one hand
via their stromal features pericytes could create a regenerative
milieu by modulating/enhancing CNS-resident progenitor cells
function and on the other hand a direct differentiation of
pericytes into CNS reparative cells would be conceivable due to
their enormous cellular plasticity.
Until now there are several studies showing a contribution of
peripheral and CNS pericytes in peripheral tissue regeneration,
but there is a lack of studies describing a regenerative
capacity of CNS and especially, retinal pericytes in CNS
tissue in vivo. In contrast, a multitude of studies report
the capacity of pericytes from various peripheral tissues to
improve and regenerate injured tissue: Crisan et al. (2008)
isolated perivascular cells (CD146+/CD34−/CD45−/CD56−)
from human skeletal muscle, pancreas, white adipose tissue
and placenta, to demonstrate their myogenic potential and
moreover the formation of myofibers after injection into the
skeletal muscle of injured mice. The myogenic potential of
human skeletal muscle pericytes was also confirmed in studies
using a muscular dystrophy mouse model, showing host-muscle
colonization and the generation of fibers expressing dystrophin
(Dellavalle et al., 2007). As these cells, next to pericyte markers
(NG2+, CD146+, aSMA+), also expressed markers typical for
MSCs, the authors suggested that MSCs may have developed
from perivascular cells/pericytes (Caplan, 2008; Crisan et al.,
2008). The potential of MSCs to differentiate into distinct
cell types such as bone, cartilage, tendon, fat or dermis and
their participation in tissue regeneration has been described
in a multitude of studies (reviewed in Caplan, 2007; Lange
et al., 2013). The similarities between pericytes and MSCs
highlight the relevance of pericytes in tissue regeneration. In
addition to pericyte participation in myogenic regeneration, the
potential to repair ischemic heart muscle has been provided
in several recent studies: transplantation of skeletal muscle
derived pericytes diminished ventricular dilatation and improved
cardiac contractility in acutely infarcted mouse hearts (Chen
et al., 2013). Avolio et al. (2015) provided evidence that
cardiac pericytes possess the ability to penetrate and colonize
xenograft tissues, which represents a potential future application
in reconstructive surgery of congenital heart diseases. However,
these cardiac ‘‘pericytes’’ were isolated by positive selection for
CD34 and negative selection for CD146, which is in contrast
used as a negative and positive selection marker respectively
in the studies of Chen et al. (2013) and Avolio et al. (2015).
This CD34+ population, located around the vasa vasorum
in the adventitia of arteries and veins, expressed pericytic
(NG2, PDGFRb, RGS5) as well as mesenchymal markers
(CD44, CD90, CD73, CD29), probably representing a further
pericyte subpopulation. Several studies report the regenerative
capacity of this CD34+ pericyte population, as demonstrated
in a mouse myocardial infarction model showing long term
improvements of cardiac function after pericyte transplantation
(Katare et al., 2011). These differences in pericyte isolation
methods clearly indicate the necessity of standardized protocols
to obtain homogenous and comparable pericyte preparations
for use in translatable, regenerative therapeutic approaches.
Furthermore, growing evidence suggests the existence of diverse
pericyte subpopulations, fulfilling different functions, most likely
also due to their varying anatomical locations. Two different
pericyte subtypes have been identified by Birbrair et al. (2013),
using a Nestin-GFP/NG2-dsRed transgenic mouse model. They
investigated the contribution of pericyte subtypes to fibrotic
tissue formation in models for diverse peripheral as well as CNS
injuries and described a particular subtype, the ‘‘type I pericyte’’
(Nestin-GFP−/NG2-dsRed+), to accumulate near the site of
injury (Birbrair et al., 2014). Furthermore, in an animal model
with lung lesion, a fraction of pericytes was additionally shown
to be involved in collagen production (Birbrair et al., 2014). The
perivascular origin of collagen producing cells/myofibroblast
has been further proposed for dermal scarring (Sundberg
et al., 1996) and kidney fibrosis models (Humphreys et al.,
2010).
Although, until now there is no study showing a positive
effect of transplanted pericytes for any eye disease, there
are some studies investigating regenerative properties of
pericyte-related cells in eye pathologies. The first indication
for a potential role of pericyte-like cells in regenerative
processes in the retinal vasculopathies has been demonstrated
by the use of adipose derived stem cells (ASCs). These
cells represent an alternative type of adult MSCs expressing
pericyte specific markers in vitro and further are able
to differentiate into pericytes (NG2+/PDGFRb+/SMA+). The
injection of ASCs after oxygen-induced retinopathy improved
microvascular regrowth, and further prevented retinal capillary
dropout in case of pre-injury injection, therefore providing
proof for functional vascular protection (Mendel et al.,
2013).
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Although the differentiation potential of CNS pericytes,
including retinal pericytes, has been demonstrated (Farrington-
Rock et al., 2004; Dore-Duffy et al., 2006; Karow et al., 2012; Paul
et al., 2012), to our knowledge no regenerative approaches have
been conducted applying CNS pericytes in any kind of in vivo
CNS (injury) models. As pericyte dysfunction and reduced
pericyte coverage plays a crucial role in disease progression and
as pericytes exhibit similar characteristics as MSCs, they seem
to be highly suitable for cell-based therapies. Moreover, with
increasing knowledge concerning CNS pericyte modulation and
differentiation, future attempts may involve molecular therapies
to modulate these cells in vivo.
CONCLUSION
Pericytes play a crucial role in maintaining tissue homeostasis,
and pericyte dysfunctions as well as a decrease in number
underlie distinct pathologies. Their involvement in numerous
diseases and their multipotency qualifies them as promising
targets for future therapeutic regenerative approaches. CNS
degenerative diseases and especially retinal degenerations often
involve pathologies of the vasculature resulting in impaired
vascular functions. As pericytes are crucially involved in vascular
physiology as well as degenerative/regenerative processes, they
are possible targets for therapeutic interventions. However, to
fully harness pericytes as molecular ‘‘drug stores’’, we need to
increase our understanding of pericyte function in health and
disease, leaving ample room for future studies.
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